These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16618425)

  • 1. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease.
    Goldberg IJ; Ginsberg HN
    Gastroenterology; 2006 Apr; 130(4):1343-6. PubMed ID: 16618425
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
    Choi SS; Diehl AM
    Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic.
    Bass NM
    Hepatology; 2010 Jan; 51(1):4-7. PubMed ID: 20034031
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
    Ginsberg HN
    Cell Metab; 2006 Sep; 4(3):179-81. PubMed ID: 16950134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
    Parekh S; Anania FA
    Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipid-supplemented total parenteral nutrition on fatty liver disease in a premature neonatal piglet model.
    Hyde MJ; Amusquivar E; Laws J; Corson AM; Geering RR; Lean IJ; Putet G; Dodds PF; Herrera E; Clarke L
    Neonatology; 2008; 93(2):77-86. PubMed ID: 17684422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver lipid metabolism.
    Nguyen P; Leray V; Diez M; Serisier S; Le Bloc'h J; Siliart B; Dumon H
    J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):272-83. PubMed ID: 18477307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P; Coracina A; Cosma A; Tiengo A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fat and lipid oxidation in humans.
    Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
    Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fasting in the non-lactating cow on hepatic lipid content and ultrastructure [proceedings].
    Reid IM; Collins RA; Baird GD
    Proc Nutr Soc; 1976 Sep; 35(2):112A-113A. PubMed ID: 972865
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
    Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and metabolism: nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver disease.
    Watts GF
    Curr Opin Lipidol; 2010 Dec; 21(6):545-7. PubMed ID: 21206342
    [No Abstract]   [Full Text] [Related]  

  • 15. [Causes of fatty liver development following partial hepatectomy and relation of this change to liver regeneration].
    Simek J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1969; 12(5):479-517. PubMed ID: 4315853
    [No Abstract]   [Full Text] [Related]  

  • 16. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
    Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
    Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
    Mine T; Miura K; Kajioka T; Kitahara Y
    Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: emerging mechanisms and consequences.
    Turkish AR
    Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):128-33. PubMed ID: 18301087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid oxidation is decreased in the liver of ovariectomized rats.
    Paquette A; Chapados NA; Bergeron R; Lavoie JM
    Horm Metab Res; 2009 Jul; 41(7):511-5. PubMed ID: 19241328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.